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cardiac resynchronization therapy (CRT) to improve the efficiency of CRT in
heart failure patients.
Methods: The study included 21 heart failure patients referred for CRT-D
implantation (LVEF=27±5.4%, QRS=149±33ms, NYHA=III-IV, 64±10 years).
Coupled pacing was delivered in association to CRT (CRT+CP) from the right
and the left ventricular leads. The CP beat was delivered 330±42 ms after R
wave during the refractory period. Echocardiography data were collected at
baseline, during CRT and CRT+CP to assess changes in left ventricular ejec-
tion fraction (LVEF), cardiac output (CO), longitudinal global strain by
speckle tracking and +dP/dt.
Results: Heart rate markedly decreased during CRT+CP (50±9 bpm vs. 78±20
bpm during CRT alone p<0.0001) and was associated to a greater increase in
LVEF compared to CRT alone (+8% p<0.0008 vs. +3.5%, p=0.01). Similarly,
+dP/dt was greater during CRT+CP than CRT alone (944±503 mmHg.ms-1 vs.
617±217mmHg.ms-1, p=0.02). In addition, peak longitudinal global strain
increased only during CRT+CP (–8±2% vs. –6±2% at baseline and during CRT,
p<0.001). Importantly, despite a decrease in heart rate during CP, cardiac output
and systolic blood pressure remained unchanged.
Conclusion: Coupled pacing in addition to CRT decreases heart rate and
contributes to a greater increase in LVEF, +dP/dt, and peak global strain
without decreasing cardiac output.
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Introduction: Cardiac Contractility Modulation (CCM) delivers non exci-
tatory electrical signals to the heart during the absolute refractory period
intended to improve contraction. It’s assessment has been previously pub-
lished on left ventricular failure by experimental and clinical studies. CCM
has never been studied yet on right ventricular failure.
Methods: We used an animal model of right ventricular barometric and
volumetric overload mimicking repaired Tetralogy of Fallot, as previously
described. Seven sheeps were operated within the first 2 months of life
(W=6+/–2 kg), they were seen back twelve months later and implanted with
CCM device. We performed hemodynamic and echocardiographic study, and
mitochondrial function analysis on right ventricular biopsies, with CCM off
and on.
Results: The hemodynamic data showed a significant improvement of RV
dP/dt max (725+/–260 mmHg/s vs 780+/–275 mmHg/s) and LV dP/dt max
(1800+/-–600 mmHg/s vs 1973+/–635 mmHg/s) with CCM on. We also found
significant improvement of mitochondrial global respiration measured by the
Acceptor Control Ratio (3.74+/-0.81 vs 5.52+/–1.68).
Conclusion: Cardiac Contractility Modulation, in an animal model of RV
dysfunction, showed significant improvement in acute hemodynamics and
mitochondrial function. The clinical implementation of this technique seems
promising.
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Electrophysiological study (EPS) is recommended in patients (pts) with
syncope, heart disease (HD), left ventricular ejection fraction (LVEF) >30%.
Implantable defibrillator (ICD) is recommended when LVEF is <30%, but is
discussed in old pts. The purpose of the study was to look for the influence of
age on the results of EPS in pts with HD.
Methods: 504 pts with HD (ischemic 386 or other origin 118) were
admitted for syncope. 303 were aged less than 70 years (group (gr) I), 155
from 70 to 79 years (gr II), 46 more than 79 years (gr III). Evaluation of
LVEF, Holter ECG, head-up tilt test were systematic. EPS included the eval-
uation of AV and sinoatrial conduction, a programmed atrial and ventricular
stimulation.
Results: Male gender was more frequent in gr I than in gr II (88% vs 79%,
p<0.01) and III (63%, p<0. 00000). LVEF was lower in group I than in gr’s
II and III (38±14 vs 42±13, p<0.006, 44.5±13, p<0.004). EPS remained neg-
ative with the same incidence in gr I (20%), II (22%) and III (24%). Mono-
morphic sustained ventricular tachycardia (VT) <270 bpm was induced as
frequently in gr I (22%), II (27%), III (27%). Ventricular flutter or fibrillation
were induced more frequently in gr I (22%) than in gr II (14%) and III (9%)
(p<0.05). The frequency of supraventricular tachycardia was similar in gr I
(16%), II (10.5%) and III (7%). AV conduction abnormality was less frequent
in gr I (6%) than in gr II (12.5%) (p<0.001) and III (14%) (p<0.009). At other
investigations, ischemic-related syncope was less frequent in gr I (9%) than in
gr II (22%) (p< 0.008) and III (13%) (NS) and hypervagotonia more frequent
in gr I (10%) than in gr II (5%) (p<0.05) and III (4% (NS).
Conclusions: Complete evaluation, including EPS is useful in elderly
people presenting with syncope and HD. VT Induction is as frequent as in
adults leading to discuss ICD implantation. AV conduction abnormalities are
frequent and a simple pacemaker implantation is enough.
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Gender differs in some heart diseases (HD). The purpose of the study was
to look for the influence of gender on the results of electrophysiological study
(EPS) in patients with heart disease (HD).
Methods: 504 patients, 85 women, 419 men were admitted for syncope.
They had an HD, either ischemic HD (n=386) or left ventricular impairment
of other origin (n=118). Echocardiography, Holter monitoring and head-up tilt
test were systematic. EPS was complete including the evaluation of AV con-
duction and sinoatrial conduction, programmed atrial and ventricular stimula-
tion (PVS).
Results: Women had the same age (66±15 years) and the same LVEF
(41±15%) as the men (64±11 years, 40±14%). Ischemic HD was less frequent
in women (67%) than in men (78%) (p<0.03). Monomorphic sustained ven-
tricular tachycardia (VT) <270 bpm was induced less frequently in women
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than in men (10 vs 26%) (<0.001). The frequency of non specific VT (ventric-
ular flutter or fibrillation) was similar in women and men (16 vs 19%). The
frequency of negative EPS was higher in women than in men (73 vs 55%)
(p<0.001). Syncope was related to hypervagotonia more frequently in women
than in men (15 vs 7%) (p<0.01). Other causes of syncope were similar in
women and men as supraventricular tachycardia (13 vs 14.5%) (NS), AV con-
duction disturbance (9 vs 8%) (NS), coronary ischemia (9 vs 8%) (NS). Non-
invasive and invasive studies remained more frequently negative in women
(27%) than in men (16%) (p<0.01). Implantable defibrillator (ICD) was
implanted less frequently in women than in men (6 vs 14%) (p< 0.04). The
frequency of sudden death (6 vs 5%) and heart failure-related death (9 vs
12%) or heart failure-related death and heart transplantation (10.5 vs 15%)
were similar.
Conclusions: Women with heart disease and syncope had less inducible
monomorphic VT than men, had more hypervagotonia and unexplained syn-
cope than men. However, despite a similar LVEF, their prognosis was similar.
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Purpose and methods: AVR by bioprothesis was performed in 268 con-
secutive patients (mean age 75±8 years) not paced previously. Incidence of
AVB was assessed during post-operative phase and follow-up (F.up). Multi-
variable analysis was performed to assess predictive factors of AVB.
Results: during post-operative phase AVB occured in 19 pts (7.1%) and
persisted in 12 patients (4.5%) requiring pacemaker (PM) implantation.
During F.up (mean 29 months) AV block requiring PM implantation occured
in 6 patients (2.3%) with a mean delay of 10 months.
In multivariable analysis predictive factors of early AVB were: previous
right bundle branch block (p=0.04), and extra corporeal circulation (ECC)
time (p=0.04). During F.up predictive factors were pre-operative bundle
branch block (p=0.04) and regressive post-operative AVB (p=0.007) Among
7 patients with regressive early AVB, 3 patients experienced recurrent AVB:
all have pre-operative bundle branch block; no recurence was observed in the
4 other patients with sharp QRS.
Conclusions: In this series early AVB after AVR occured in 7.1% of
patients and required PM implantation in 4.5%. During F.up AVB occured in
6 patients. Predictive factors of AVB were previous right bundle branch block
and ECC time for early AVB, previous bundle branch block and regressive
early AVB for late AVB. All patients with regressive early AVB and previous
bundle branch block have recurence of AVB in F.up and should be considered
for early PM implantation.
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Introduction: Familial amyloid polyneuropathy (FAP) is an autosomic
dominant disease induced by the mis-folding of a mutated precursor of
Albumin (transthyretin). Cardiopathy due to FAP include myocardial infiltra-
tion and conduction disturbances.
The Val30Met mutation is the most common. The aim of our study was to
compare electrophysiological characteristics of the Val30Met population to
other FAP population.
Methods & Results: Data from 121 patients with genetically proven FAP
were analysed. Standard ECG, echocardiography and electrophysiological
study were performed. Surface ECG was abnormal in 47% (NS). Main results
are shown in the following table:
Conclusion: Electrophysiological parameters differed significantly in car-
diac amyloidosis due to FAP according to the genotype. Amongst patients car-
rying other mutation than Val30Met, cardiac infiltration and infra nodal block
were more common and seemed to be related.
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In cardiac resynchronization therapy (CRT) procedure, left ventricular lead
(LV) implantation is time-consuming. In this clinical setting, no study has
investigated the impact of right atrium anatomical parameters on both CRT
implantation procedure duration and X-ray exposure. Additionally, only few
studies have examined the coronary sinus (CS) using dual source 64-Multi
Slice Computed Tomography (DS 64-MSCT), and its impact on CRT proce-
dure parameters has not yet been investigated.
The aim of this prospective study was to identify local anatomical predic-
tive factors of difficult CRT implantation procedure using DS 64-MSCT.
Between January and July 2010, 50 consecutive patients underwent primo
CRT implantation. The patient population had a mean age of 70±10 years with
NYHA Class 3.2±0.3 heart failure, LVEF 30±4%, and QRS width
157±30 ms. CRT implantation was attempted in 50 patients, and first LV lead
implantation was obtained in 49/50 patients (98%).One implantation (2%)
failed due to unsuccessful LV lead implant. Procedure parameters were as fol-
lows:median procedure time (skin to skin), 51 min (38 min); median fluoros-
copy procedure time, 11.9 min (22 min); median LV fluoroscopic time, 10.3
min (22 min). In 10 patients (20%), procedures were difficult requiring an
implantation lasting 85 min. The only predictive factor for difficult CRT
implantation was the insertion level of the CS ostium (CSO), evaluated by the
distance between the CSO and the bottom floor of the right atrium.
Conclusions: Today, despite improvements in the materials used problems
still remain in CRT procedure. In this clinical setting, the only predictive
factor for very long CRT procedures is the CSO level insertion (located
high).This anatomical anomaly is responsible for 20% of difficult CRT device
implantation procedures. Taking this anatomical parameter into account as
evaluated by DS 64-MSCT prior to surgery may help operators reduce both
operating and fluoroscopy times.
Val30Met other mutations P
n 87 34
age 42±13 54±8 <0.0001
IVS (mm) 11±3 13±3 <0.0001
AH interval (ms) 113±38 94±17 0.007
Wenckebach point (bpm) 126126±32 154±23 <0.0001
HV interval (ms) 60±12 68±16 0.004
HV interval was 70 ms in 39% of the patients. In patients carrying other 
mutations than Val30Met, cardiac infiltration assessed by IVS thickness was 
correlated with a longer HV interval (R=0.63, P=0.0003). Such association 
wasn't found considering Val30Met patients.
